Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi.
AuthorsMakombe, S D
Harries, A D
Yu, J K L
Schouten, E J
AffiliationClinical HIV Unit, Ministry of Health, PO Box 30377, Lilongwe, Malawi.
MetadataShow full item record
AbstractAIDS-associated Kaposi's sarcoma (KS) is the most common AIDS-related malignancy in sub-Saharan Africa, with a generally unfavourable prognosis. We report on six-month and 12-month cohort treatment outcomes of human immunodeficiency virus (HIV)-positive KS patients and HIV-positive non-KS patients treated with antiretroviral therapy (ART) in public sector facilities in Malawi. Data were collected from standardized antiretroviral (ARV) patient master cards and ARV patient registers. Between July and September 2005, 7905 patients started ART-488 (6%) with a diagnosis of KS and 7417 with a non-KS diagnosis. Between January and March 2005, 4580 patients started ART-326 (7%) with a diagnosis of KS and 4254 with a non-KS diagnosis. At six-months and 12-months, significantly fewer KS patients were alive and significantly more had died or defaulted compared to non-KS patients. HIV-positive KS patients on ART in Malawi have worse outcomes than other patients on ART. Methods designed to improve these outcomes must be found.
PublisherRoyal Society of Medicine
- Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi.
- Authors: Makombe SD, Harries AD, Yu JK, Hochgesang M, Mhango E, Weigel R, Pasulani O, Fitzgerald M, Schouten EJ, Libamba E
- Issue date: 2007 Apr
- Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
- Authors: van Oosterhout JJ, Brown L, Weigel R, Kumwenda JJ, Mzinganjira D, Saukila N, Mhango B, Hartung T, Phiri S, Hosseinipour MC
- Issue date: 2009 Aug
- [The introduction of antiretroviral therapy in Malawi].
- Authors: Zijlstra EE, van Oosterhout JJ
- Issue date: 2006 Dec 16
- Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi.
- Authors: Bong CN, Chen SC, Jong YJ, Tok TS, Hsu CF, Schouten EJ, Makombe SD, Yu JK, Harries AD
- Issue date: 2007 May
- Risk of cancers during interrupted antiretroviral therapy in the SMART study.
- Authors: Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI
- Issue date: 2007 Sep 12